Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+

Clinical trial NCT06874530 · RECRUITING

Trial details

NCT number: NCT06874530
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status: RECRUITING
Study type: OBSERVATIONAL

Multiple Mieloma

Start date: 2023-12-27
Primary completion: 2025-11-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.